VIOG - ETF AI Analysis
Top Page
Vanguard S&P Small-Cap 600 Growth ETF (VIOG)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and solid momentum over the past three months, which indicates that its strategy has been working well in the current market.
Growing Small-Cap Growth Holdings
Many of the top 10 stocks, including several health care and technology names, have delivered strong year-to-date performance, helping drive the fund’s overall returns.
Low Expense Ratio
The fund’s low annual fee means investors keep more of the returns generated by its holdings compared with higher-cost ETFs.
Negative Factors
U.S.-Only Exposure
Almost all of the ETF’s assets are invested in U.S. companies, so it offers little geographic diversification if the U.S. market weakens.
Small-Cap Volatility Risk
Because the ETF focuses on small-cap growth stocks, its share price can be more sensitive to market swings and economic uncertainty than funds holding larger, more established companies.
Sector Tilt Toward Industrials and Growth Areas
The fund has relatively heavy exposure to sectors like industrials, technology, and health care, which can hurt performance if these growth-oriented areas fall out of favor.
VIOG vs. SPDR S&P 500 ETF (SPY)
AUM1.09B
RegionNorth America
Expense Ratio0.10%
Beta0.98
IssuerVanguard
Inception DateSep 07, 2010
Dividend Yield0.76%
Asset ClassEquity
Index TrackedS&P Small Cap 600 Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume26,810
30 Day Avg. Volume34,182
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
176.77Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering347
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VIOG Summary
Vanguard S&P Small-Cap 600 Growth ETF (VIOG) is a fund that follows the S&P Small Cap 600 Growth index, focusing on smaller U.S. companies with strong growth potential. It spreads your money across many industries, including technology, health care, and industrials. Well-known names in the fund include Etsy and ViaSat, along with many lesser-known firms that may still be in earlier stages of growth. Investors might choose VIOG to add diversification and long-term growth potential from small, innovative companies. A key risk is that small-cap growth stocks can be more volatile and may go up and down sharply with the market.
How much will it cost me?The Vanguard S&P Small-Cap 600 Growth ETF (VIOG) has an expense ratio of 0.10%, which means you’ll pay $1 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The Vanguard S&P Small-Cap 600 Growth ETF (VIOG) could benefit from economic growth and innovation in sectors like technology and industrials, which make up a significant portion of its holdings. However, small-cap stocks are often more sensitive to economic downturns, interest rate hikes, and market volatility, which could negatively impact the ETF's performance. Additionally, changes in U.S. regulations or sector-specific challenges could influence the growth potential of its top holdings.
VIOG Top 10 Holdings
VIOG leans into U.S. small-cap growth, with a cast of niche players rather than household names. Health care names like Corcept Therapeutics and Protagonist Therapeutics have been rising, giving the fund a helpful tailwind, while Alkermes adds steady biotech strength. On the tech and industrial side, ViaSat has been climbing, but FormFactor and Argan have seen more mixed, recently lagging action, occasionally putting sand in the gears. Overall, the ETF spreads its bets across growthy industrials, tech, and health care, keeping sector risk balanced within the U.S. market.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ViaSat | 1.10% | $11.93M | $9.67B | 372.31% | 56 Neutral | |
| Corcept Therapeutics | 1.02% | $11.11M | $9.98B | 76.15% | 76 Outperform | |
| Brinker International | 1.02% | $11.04M | $8.82B | 33.16% | 70 Neutral | |
| Ryman | 0.99% | $10.70M | $8.56B | 40.17% | 66 Neutral | |
| Etsy | 0.94% | $10.16M | $8.12B | 42.70% | 57 Neutral | |
| Alkermes | 0.93% | $10.08M | $8.11B | 88.86% | 80 Outperform | |
| Protagonist Therapeutics | 0.93% | $10.06M | $8.55B | 157.41% | 68 Neutral | |
| Esco Technologies | 0.90% | $9.72M | $7.77B | 60.82% | 70 Neutral | |
| Zurn Water Solutions | 0.88% | $9.58M | $8.55B | 13.26% | 79 Outperform | |
| StoneX Group | 0.88% | $9.54M | $8.57B | 79.60% | 58 Neutral |
VIOG Technical Analysis
Positive
―
Price Trends
145.97
Positive
138.75
Positive
131.58
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VIOG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 148.86, equal to the 50-day MA of 145.97, and equal to the 200-day MA of 131.58, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VIOG.
VIOG Peer Comparison
Comparison Results
Performance Comparison
VIOG
Vanguard S&P Small-Cap 600 Growth ETF
148.36
36.15
32.22%
FNDA
Schwab Fundamental US Small Co. Index ETF
―
―
―
IJT
iShares S&P Small-Cap 600 Growth ETF
―
―
―
SLYG
SPDR S&P 600 Small Cap Growth ETF
―
―
―
VTWG
Vanguard Russell 2000 Growth ETF
―
―
―
FYC
First Trust Small Cap Growth AlphaDEX Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents